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Sulphide Donor, Intracerebral MSCs, Ginko Biloba and Kefir in 
Attenuating Neuropathological hallmarks of Lipopolysaccharide 
induced Alzheimer's disease Rat models                                                            
Background: Memory disorders have been characterized by being a 
devastating long term incurable diseases with a huge social impact in 
addition to a diminished efficient available medical treatments. Deep 
Brain stimulation via using neuroprotective inducers for treatment of 
brain structure degenerative diseases such as Alzheimer’s disease 
(AD) can be considered as being a promising successful therapy due 
to its various targets and underlying mechanisms for improving brain 
dysfunction. Objectives: The main aim of this study is to suggest ther-
apeutic protocol having the potentials for restoring normal neurons di-
verse population and modifying neuropathological deposited hallmarks 
including both positive and negative lesions. Materials and Methods: 
Rats were divided into nine groups: (G1) control ;(G2) rats received 
LPS as a method of inducing nongenetically manipulated AD;(G3)AD 
rats received NaHS;(G4) AD rats received MSCs intracerebrally;(G5) 
AD rats received MSCs+NaHS;(G6)AD rats received kefir+GB;(G7)AD 
rats received MSCs+kefir+GB;(G8)AD rats received NaHS+kefir+GB; 
(G9) AD rats received MSCs+NaHS+kefir+GB. Results: AD induction 
resulted in down-regulation of CBS expression and GSH brain tissue 
level accompanied with overexpression in amyloid-β protein, MAPK, 
tau protein, ACAT expression and MDA brain tissue level in addition 
to elevated caspase-3 serum level. Conclusion: The implantation of 
amyloid reliving therapy that do have a wide clinical impact if initiated 
at benign plaques stage before irreversible brain damage occurs. The 
following effects have been observed following the administration of 
suggested medical protocol where a decrease in AD pathological de-
posited hallmarks has been observed with maintaining inflammatory 
brain factors by functioning as a potent neuroregenerative.
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Introduction 
Neuroregeneration is a continual regrowth/ 
repairing processes for various types of nervous 
cells and damaged brain tissues whether 
located in the peripheral or central nervous 
system for restoring normal brain function 
abilities and maintained synaptic transmission 
system. A clear understanding of a neuro-
regenerative functions and the relation that can 
be established for restoring the attenuated 
mental abilities in neurodegenerative diseases 
such as Alzheimer’s disease (AD) must be 
clearly stated to clarify its efficiency. Alzheimer’s 
disease is the most common type of dementia 
characterised by altered behavioural symptoms, 
memory loss, aphasia, cognitive deterioration 
and apraxia [1]. Difficulty with accepting new 
information and memory recall failure are the 
most common drawbacks of numerous amyloid-
β aggregations and neurofibrally tangles located 
intracellularly within the brain of AD patients [2-
3]. Foreign substance identified as fibrillated 
amyloid-β peptides can oligomerize and 
aggregate forming diffuse plaques (benign 
plaques) which on the long run turn into neuritic 
plaques (irreversible form) being produced by 
processing amyloid precursor protein (APP) via 
β- and γ-secretases enzymes respectively 
leading to synaptic dysfunction and neuronal cell 
death. The processing of APP to Aβ 
amyloidogenic pathway can be enhanced by 
overlapping inflammatory signals pathways and 
mediators including apoptotic regulator factors, 
oxidative stress and excessive lipid foam cells 
[4-7]. Alzheimer’s disease can also be related to 
an observed decreased in frontal and temporal 
lobe metabolism characterized by atrophy of 
cortex and hippocampus brain regions with 
defective alterations in memory networks and 
neuronal circuitry [4-5]. Thus, AD can be newly 
defined as a degenerative mental disease with 
over all systemic immunological body disorders 
affecting various biological integrated pathways 
leading to exaggerated unmaintained 
proinflammatory triggering factors [6-7]. 
Lipopolysaccharide as an inducer of 
nongenetically manipulated AD type 
Toll-like receptors (TLRs) are evolutionary 
conserved type I integral membrane 
glycoproteins which can sense either pattern 
associated molecular patterns (PAMPs) and/or 
damage-associated molecular patterns 
(DAMPs). Lipopolysa-ccharides (LPS) is the 
major inducer of pro-apoptotic factors, 
inflammatory cytokines, chemokines, 
prostaglandins, and nitric oxide. LPS/TLR4 
induce endotoxin cascade starts with recognition 
of PAMPs by pattern recognition receptor (PRR), 
activating several specific targeting proteins 
including cluster of differentiation 14 (CD14) 
,MD2 and Toll/IL-1 receptor(TIR) domain [8]. 
The activation of the TLR4/MD-2 complex after 
binding LPS leads to the initiation of 
proinflammatory signalling components evoked 
by intracellular neuronal activation of tumor 
necrosis factor-alpha (TNF-α), nuclear factor 
kappa B (NF-ĸβ),mitogen activated protein 
kinase (MAPK) and c-Jun N-terminal kinases 
(JNK activation [8-9]. 
Exogenous hydrogen sulphide donor and AD 
The out breaking discovery of endogenously 
produced H2S in the brain prompted us to find 
out the enzyme responsible for its production 
which found out to be mainly produced by 
cystathionine β-synthase (CBS) pyridoxal-5-
phosphate-dependent enzyme predominantly 
found in the central nervous system [10]. 
Hydrogen sulphide (H2S) is a neuromodulator 
cytotoxic gas which has the ability to protect 
neuron cells and synapse from apoptotic 
regulators, inflammatory cytokines and oxidative 
stress. The production of H2S in the brain is 
mainly enhanced in response to  regular 
neuronal  excitation  via  the  Ca2+and  
calmodulin-mediated  pathways potentiating 
neurotransmission by acting as a 
neuromodulator influencing N-methyl-D-
aspartate (NMDA) receptors and corticotropin-
releasing  hormone  from  the  hypothalamus 
[10]. Potential therapeutic value of H2S was 
clearly found to be useful in several 
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neurodegenerative diseases including AD, 
Parkinson’s disease and traumatic brain injury 
via acting as neuroprotectant, antioxidant, anti-
inflammatory, and antiapoptotic [11]. Based on 
these observations, H2S production is 
suppressed by AD accompanied aggregations 
as a result of a proportional inhibition of CBS 
enzyme. Meanwhile our resent study provides a 
suggestion for alternative exogenous source of 
hydrogen sulphide to compensate its deficiency 
following AD hallmarks disposition in addition to 
preventing AD predicted progression and 
undesirable drawbacks. 
Intracerebral MSCs and AD 
Mesenchymal stem cells (MSCs) can be defined 
as a promising adjuvant cell regenerative 
therapy which can be used in various diseases 
including AD whether administrated I.V 
systemically or localized intracerebrally via 
tissue repair mechanism and regenerating tropic 
factors releasing strategy such as brain-derived 
neurotrophic factor (BDNF) based upon the 
origin and innate characteristic functions of the 
stem cells [12-14]. Neurons cells repair, 
decreased apoptotic inflammatory factors, 
reduced free radicals level and activated 
synaptic connection from damaged neurons 
were observed mainly upon MSCs brain 
transplantation by the ability to engulf Aβ 
aggregates which can be mainly attributed to 
microglial cell activation [13,14]. 
Ginko Biloba and AD 
Natural products have been recently 
investigated and used as a regenerative therapy 
for their ability to induce cells neural proliferation, 
differentiation and brain function integrity. A 
combination therapy of kefir and Ginko Biloba 
(GB) have been used in the present study 
targeting their beneficial complex pathology for 
the treatment of AD mental disorders due 
various therapeutic mechanism of action [15-
17]. Ginko Biloba (GB) can promote 
neurogenesis in brain trauma and injury 
conditions by augmenting physiological neural 
repair mechanisms through the release of 
growth and tropic factors [18-20]. Most of the 
neuroprotective actions of GB are so-called 
polyvalent actions including antioxidant and anti-
inflammatory activity via increasing cerebral 
blood flow and modulating neurotransmitter 
activity which can be linked to flavone glycosides 
and terpenoids active constituents [21]. Ginko 
Biloba exerts also a beneficial effect against 
amyloid beta (Aβ)-induced free radical-mediated 
neurotoxicity hypothesis through the stimulation 
of NGFR (nerve growth factor receptor)/PI3 
kinase-mediated cell survival pathway, inhibition 
of MAPK cascade, antioxidant free radical 
scavenger activity and anti-apoptotic actions 
[18-21]. 
Milk Kefir grains and AD 
Kefir is a cultured fermented milk product 
produced using milk kefir grains, where it found 
to produce a slightly acidic and foamy milky 
drink. Kefir grains consist mainly of lactic acid 
and acetic acid bacteria (lactobacilli, lactococci, 
Leuconostoc) and yeasts, which coexist as a 
complex symbiotic association in a protein–
polysaccharide matrix [22]. Kefir probiotic micro-
organisms can exert their several health-
beneficial functions as neuromodulator, 
immunostimulant, anti-inflammatory and anti-
oxidant effects through wide different 
mechanisms including complete competitive 
exclusion or inhibition of pathogenesis, immune 
response modulation and regulation of 
metabolic functions [23-25]. 
The main aim of the current study is to provide a 
safe quaternary combination therapy composed 
of mesenchymal stem cell and/or NaHS and/or 
kefir and GB with the ability to restore mental 
and behaviour abnormalities as a results of AD 
hallmarks brain disposition within neural cells by 
neural ravishing regeneration mechanisms, 
restoring synaptic transmission activity , 
releasing tropic factors and attenuating pro-
inflammatory triggering agitators with the 
advantage of being easily administrated and 
implemented on human research subjects to be 
used clinically. 
2. Materials and methods 
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2.1. Materials used 
Sodium hydrogen sulphide (NaHS) and 
Lipopolysaccharides (LPS) were purchased 
from (Sigma-Aldrich, St. Louis, MO), GB extract 
was obtained from Pharaonia Pharmaceuticals 
Egypt, dried Kefir grains were purchased from 
Cultures for Health (17978 S, Grasle Rd. Ore. 
City OR 97045, United States), Dulbecco’s 
Modiefied Eagle’s Medium (DMEM) and 
Phosphate buffered saline (PBS) were 
purchased from (Lonza) and RNeasy lysis buffer 
(RLT) (QIAGEN). 
2.2. Preparation of milk Kefir grains: 
20 mg of dried kefir grains were inoculated in 
100 ml of pasteurized milk following by 
incubation for 24 h at 20°C. At the end of 
fermentation, milk was filtered to remove kefir 
grains [12,26]. 
2.3. Preparation of Ginko Biloba (GB): 
Rats administrated 100mg/kg single daily dose 
of GB by oral gavage for 15 days with slight dose 
modifications [27]. 
2.4. Preparation of exogenous hydrogen 
sulphide (NaHS): 
Rats received NaHS intraperitoneally (IP) at a 
daily dose of 5 mg/kg dissolved in deionized 
water for 15 days with slight dose modification 
[28]. 
2.5. Preparation of Bone Marrow (BM) 
derived MSCs: 
Mesenchymal stem cell were isolated by flushing 
tibia and femur with DMEM from five adult male 
albino rats in accordance with density gradient 
[Ficoll/Paque (Pharmacia)] followed by re-
suspension with 1% penicillin-streptomycin and 
10% fetal bovine and left to be incubated at 37°C 
for 12–14 days in 5% humidified CO2 till the 
formation of large colonies followed by direct 
twice times washing with PBS (pH7). Cells were 
then trypsinized with 0.25% trypsin in 1mM 
EDTA at 37°C for 5 min then incubated in 50 cm2 
culture flasks following centrifugation. MSCs 
were identified by adhesiveness, fusiform 
characteristic shape and ability to differentiate 
into osteocytes and chondrocytes (Jaiswal et al., 
1997). The morphological characters of cell 
surface molecules expression were analyzed 
using flow cytometry procedures for CD45-ve, 
CD 90, and CD105+ve as shown in figure 1(A). 
2.6. Identification and labeling of BM-MSCs 
Bone marrow derived mesenchymal stem cells 
were labeled with PKH26 red fluorescence cell 
linker kit prior to being transplanted according to 
the manufacturer’s recommendations (Sigma, 
Saint Louis, Missouri, USA). Cells were 
centrifuged, washed, pelleted and suspended 
respectively in PKH26 dye solution. One month 
post transplantation, labeled MSCs with PKH26 
were tracked and visualized using a 
fluorescence microscope (Sigma-Aldrich, Saint 
Louis, USA) as shown in figure 1(B). 
2.7. Animals 
 Seventy-two (72) male albino rats, weighing 
200- 250 g were purchased from the 
experimental animal facility unit, Faculty of 
Medicine, Cairo University. Rats were 
maintained in sterile pathogen free controlled 
temperature animal house at 22°C in a 12-h 
light/dark cycle with free access to water and 
semi-purified diet containing (g/kg): 100 g 
casein, 750 g sucrose, 50 g cellulose, 50 g fat 
blends, 10 g vitamin mix, and 40g mineral mix. 
All animal treatment ethical protocols were 
undertaken in accordance with animal facility 
ethical standard unit of Faculty of Medicine, 
Cairo University with the approval of Institutional 
Animal Ethics Committee. 
Induction of Alzheimer’s disease by 
lipopolysaccharide 
 The induction of Alzheimer’s disease in the 
successive eight constructed groups of rats 
subjected to study treatment protocol  was done 
by (IP) injection with 0.56 mg/ kg body weight of 
LPS dissolved in 1 ml of sterile PBS (pH 7) as a 
modified single dose [30]. 
2.8. Experimental design 
Healthy male albino rats were divided randomly 
into nine equal constructed groups (eight rats 
each), fed on a semi purified diet for a period of 
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time one week prior to study initiation process. 
The experiment was designed as follow: 
• G1 (control): Eight healthy rats acting as 
negative control group. 
• G2 (AD):  Alzheimer’s disease was induced 
in rats by (IP) injection with 0.56 mg/kg body 
weight of lipopolysaccharides dissolved in 1 
ml of sterile PBS as a modified single dose 
[30]. 
• G3 (AD+NaHS): LPS induced rats received 
NaHS (IP) at a daily single dose of 5 mg/kg 
dissolved in deionized water for 15 days with 
dose modification [28]. 
• G4 (AD+MSCs): LPS induced rats received 
MSCs intracerebrally in a single dose 
administration protocol at 5 μl (5×105) in 
PBS-10% following being anthesized with 1 
ml/kg solution of 80 mg/kg/i.m of ketamine 
hydrochloride with dose modifications 
[31].The site of rats intracerebral injection 
was estimated approximately half way 
between the eye, ear and just off the midline 
[32-34]. 
• G5 (AD+MSCs+NaHS): LPS induced rats 
received MSCs intracerebrally in a single 
dose administration protocol at 5 μl (5 × 105) 
in PBS-10% with slight modifications [31] 
accompanied with a daily (IP) single 
administration of NaHS at dose of 5 mg/kg 
dissolved in deionized water for 15 days with 
dose modification [28]. 
• G6 (AD+kefir+GB): LPS induced rats 
received 4ml/kg body weight of milk kefir by 
oral gavage once daily for a month with slight 
dose modification (12,26) accompanied with 
concurrent single oral dose administration of  
100mg/kg GB for 15 days with slight dose 
modification [27]. 
• G7:(AD+MSCs+kefir+GB):LPS induced rats 
received MSCs intracerebrally followed by a 
daily oral dose administration of kefir for a 
month concurrently with GB for 15 days. 
• G8:(AD+NaHS+kefir+GB): LPS induced rats 
received NaHS (IP) at a single daily dose for 
15 days followed by a daily oral dose 
administration of kefir for a month 
concurrently with GB for 15 days. 
• G9:(AD+MSCs+NaHS+kefir+GB):LPS 
induced rats received MSCs intracerebrally 
with a subsequent (IP) injection of NaHS 
once daily for 15 days followed by a daily oral 
dose administration of kefir for a month 
concurrently with GB for 15 days. 
2.9. Morris Water Maze (MWM) 
After one month of applying suggested 
treatment protocol therapy, rats were trained to 
perform MWM in order to study the effect of 
given treatments on rat’s impaired memory as a 
result of inducing AD which will be reflected on 
rat's time performance to reach the platform. 
Rats were placed in a circular blue pool (6 feet 
in diameter) filled with 26 ± 2◦C water  with a 
circular escape platform placed in the middle of 
the target quadrant 2 cm below the water surface 
where during training it can be exposed 1 inch 
above the water. Rats were subjected to four 
trials per day. On the fifth day, a trial 
performance test was undertaken with recording 
the time taken by each rate to reach the platform 
(latency time) in accordance with mental 
functions restoring mechanisms by the 
suggested administrated therapy and brain 
tissue histopathological studies.  
2.10 Blood sampling and preparation: 
 Following performing Morris test and before 
decaptation, blood was collected from the retro-
orbital vein of rats, left to clot for 30 min and 
separated by centrifugation for 20min at 10,000 
xg. Serum was kept frozen till the analysis of 
Caspase-3 activity level which was estimated 
using the ELISA technique (Cusabio 
Biotech,China) according to the manufacture’s 
instruction. Animals were then anesthetized with 
sodium phentobarbital (60 mg/kg), killed by 
decapitation following brain tissue extraction. 
2.11 Tissue sampling and preparation: 
Brains were rapidly removed and cut into four 
transverse symmetrical halves by midline 
incision. One half was fixed in 10% formalin for 
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histopathological studies accompanied with 
MSCs labelling step using PKH26 red 
fluorescence cells linker kit. The other two 
halves were lysed in a specific designed different 
manners where one was prepared to perform 
tissue estimation of CBS relative expression 
using Quantitative Reverse Transcription 
polymerase chain reaction (QRT PCR), while the 
other half was prepared to perform brain tissue 
estimation of MAPK, Tau protein and ACAT 
expression by western blotting. The remaining 
half was left for brain tissue estimation of Aβ42 
level by ELISA in addition to Malondialdehyde 
(MDA) and Glutathione (GSH) by 
spectrophotometer. 
2.11.1 Detection of CBS relative expression 
by QRT PCR: 
The Purification and extraction step of total RNA 
from rats brain tissue using EZ-10 Spin Column 
Total RNA Mini-Preps kit (Bio Basic 
Inc.,Canada) was done by tissue 
homogenization using RLT lysis buffer and pure 
ethanol followed by centrifugation for 30 sec at 
12,000 xg room temperature. The extracted 
RNA was reverse transcribed into 
complementary DNA (cDNA) using a 
QuantiTect® Reverse Transcription Kit 
(QIAGEN).PCR primers were specifically 
designed with Gene Runner Software (Hasting 
Software, Inc., Hasting, NY) from RNA 
sequences assigned from gene bank (Table 1). 
Relative expression of CBS was calculated 
using the comparative Ct method by 2-ΔΔCq 
method. All values have been normalized to the 
β-actin gene and been reported as fold change 
over background levels detected in Alzheimer’s 
disease.  
2.11.2 Estimation of brain tissue expression 
of MAPK, Tau protein and ACAT by western 
blotting: 
Brain tissue protein extraction was performed 
using RIPA lysis buffer (sodium chloride, 1.0% 
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% 
SDS, 50 mM Tris at pH 8.0, protease and 
phosphatase inhibitor cocktails). The cell lysates 
were shaken continuously and kept 1hr in ice 
prior to centrifugation at 12,000 g for 10 min 4°C. 
Obtained supernatants were denatured by SDS 
sample buffer directly by heating the protein 
samples for 5 min at 95°C. Estimated equal 
amounts of protein samples were separated by 
electrophoresis using a 10% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis 
(SDS/PAGE) and directly been transferred onto 
a nitrocellulose membrane (Whatman®, 
Germany). After being blocked using 10% milk 
with TBST buffer (10 mM Tris-HCl, 120 mM 
NaCl, 0.1% Tween-20, pH 7.4) and kept at room 
temperature for 1 hr, the membranes were 
incubated and probed with corresponding 
primary antibodies (Tau Polyclonal Antibody 
from BioVision, p38 MAPK (D13E1) XP® Rabbit 
mAβ from cell signalling technology and ACAT 
Polyclonal Antibody from BioVision) at 4°C 
overnight. Visualization was carried out using 
ECL® (plus/advanced chemi-luminescence) kit 
(GE healthcare, UK) as shown in figure (3C).  
2.11.3 Estimation of Aβ42 by ELISA in 
addition to Malondialdehyde (MDA) and 
Glutathione (GSH) by spectrophotometer. 
Brain tissue was rinsed and homogenised using 
1xPBS stored overnight at -20°C. After two 
freeze-thaw cycles were performed to break the 
cell membranes, the homogenates were 
centrifuged for 5 minutes at 5000 xg 2-8°C. The 
obtained supernatant was removed and 
assayed immediately according to manufacturer 
instruction Aβ1-42 (Cusabio, China), 
Glutathione and MDA (Biodiagnostic). 
2.12 Histopathology: 
 Autopsy samples were taken from rat’s brain 
tissue and fixed in 10% saline for twenty-four 
hours. Washing was done with deionized water 
followed by washing with a specified serial 
dilutions of alcohol (methyl and absolute ethyl 
alcohol) for the purpose of dehydration process. 
Specimens were directly cleared using xylene 
and placed in paraffin at 56º in sterilized oven for 
twenty four hours. Paraffin bees wax blocks 
were prepared for sectioning at 4 microns 
thickness by sledge microtome. The obtained 
tissue sections were collected for examination 
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on glass slides, deparaffinised followed by 
staining with haematoxylin and eosin using light 
electric microscope [35]. 
2.13 Statistical analysis 
 The results for eight animals per group were 
expressed in the form of mean ± standard error 
(mean± SE). One-way analysis of variance 
(ANOVA) was used for the purpose of 
comparing variables among subjected groups. 
The pairwise comparisons were conducted 
using the Mann-Whitney U test. Obtained values 
at p < 0.05 were considered significant. Data 
were statistically analysed using the statistical 
package for social sciences18 software (SPSS, 
Chicago, IL, USA). 
 
Table 1: Sequence of the primers used for real-time PCR Primer 
CBS 
Forward primer: 5′ ATGCTGATCGCGCAAGAG 3′ 
Reverse primer: 5′ TCGCTCAGGAACTTGGTCAT 3′ 
β-actin 
Forward primer : ’5 CCAGGCTGGATTGCAGTT ’3  
Reverse primer: ’5 GATCACGAGGTCAGGAGATG ’3  
 
 
 
Figure 1A: Characteristics of BM-MSCs. Cells were stained with CD45-ve (A), CD90 +ve (B) 
and CD105+ve (C) antibody using flow cytometry.  
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Figure 1B: Detection of MSCs labelled with PKH26 fluorescent dye in rat’s brain tissue. The 
presence of red fluorescent (arrows) indicating homing of MSCs in brain tissue in group 
(G4,G5,G7&G9). 
 
 
Figure 2A: Effects of NaHS, MSCs, Kefir with concurrent administration of GB and/or in an 
alternative manner on latency time % change consumed by rats in MWM. The same small 
letter means insignificant different between treated groups using Mann-Whitney U test (P> 
0.05). 
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3. Results 
3.1 LPS induction resulted in complete 
memory impairment in rats with gradual 
improvement following the administration of 
suggested medical protocol as observed by 
rat’s performance in MWM 
To determine the exact role and efficacy of the 
suggested therapeutic protocol in attenuating 
the neural cell damage and AD hallmark 
precipitation post to LPS administration, MWM 
was conducted. The obtained results reveal that 
LPS challenged rats spent the longest time in the 
conducted maze when compared with the 
control non-treated group and/or with the other 
subjected treated groups as shown in figure 2 
(A). Results clearly observed the vital role of H2S 
in improving the impaired memory of the LPS 
induced rats whether administrated alone or in 
simultaneous administration with MSCs and /or 
combination therapy of kefir and GB. The 
efficiency of intracerebral administration of 
MSCs in improving memory deterioration 
drawbacks was reflected on time consumed by 
the rats in maze when compared with control, 
untreated and treated groups. The concurrent 
administration of NaHS as an exogenous donor 
of H2S with MSCs, kefir and GB displayed the 
most pronounced improvement in memory 
functions and abilities of LPS challenged rats 
which can be further supported due to their 
synergistic actions. 
3.2 Administration of NaHS and/or MSCs 
and/or kefir and GB decreased MAPK, Tau 
and ACAT brain tissue relative expression 
accompanied with a significant increase in 
CBS brain tissue level in LPS induced rats 
Intraperitoneal LPS injection (IP) to rats 
significantly increased the expression level of 
tau protein , MAPK and ACAT brain relative 
expression accompanied with a marked 
decrease in CBS brain tissue expression level 
when compared with the negative control group 
(G1) as shown in figure 3(A,B,C&D).The  
administration of NaHS whether alone and/or 
intracerebral MSCs and/or combination therapy 
of kefir and GB significantly attenuated the 
expression of tau protein, MAPK and ACAT 
relative expression with a significant increase in 
CBS tissue level. The obtained results also 
revealed the efficacy of intracerebral 
administration of MSCs whether administrated 
alone or in combination therapy of kefir and GB 
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Figure (3): Effects of NaHS, MSCs, Kefir with concurrent administration of GB and/or in an 
alternative manner on % of change of CBS, Tau , MAPK and ACAT relative expression on LPS 
induced rats with respect to control (G1). The same small letter means insignificant different 
between treated groups using Mann-Whitney U test (P>0.05). % change corresponding to 
control group (G1). 
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Figure 4(A):Effects of NaHS, MSCs, Kefir with concurrent administration of GB and/or in an 
alternative manner on % of change of Aβ1-42 (pg/mg ptn) brain tissue level  and Casp-3 serum 
activity level (ng/ml) on LPS induced rats with respect to control (G1).The same small letter 
means insignificant different between treated groups using Mann-Whitney U test (P>0.05). % change 
corresponding to the negative control group (G1). 
 
 
Figure 4(B&C): Effects of NaHS, MSCs, Kefir with concurrent administration of GB and/or in 
an alternative manner on % of change of MDA level (nmol/gm ptn) and GSH (mmol/gm ptn) 
brain tissue level on LPS induced rats with respect to control (G1).The same small letter means 
insignificant different between treated groups using Mann-Whitney U test (P>0.05). % change 
corresponding to the negative control (G1). 
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on decreasing the expression level of tau 
protein, MAPK and ACAT with an increase in 
CBS brain tissue expression level when 
compared with negative control group (G1) with 
an observed improvement following the 
administration of combination therapy of kefir 
and GB in all previously mentioned brain tissue 
parameters. The concomitant co-administration 
of NaHS, MSCs and combination therapy of kefir 
and GB displayed an additive ameliorating role 
in decreasing the elevated level of tau protein, 
MAPK and ACAT with a well-marked 
improvement in the level of CBS relative when 
compared with negative control group (G1). 
 
 
Figure 5: Histopathological examination of rat’s brain tissue in: (A) negative control group 
(G1)(H& Ex40):showing normal histological structure of neurons in fascia dentate & hilus of 
hippocampus.(B): AD positive group (G2) (H&Ex40) showing nuclear pyknosis and 
degeneration in neurons of fascia dentate & hilus of hippocampus.(C):AD+NaHS (G3) 
(H&Ex40) showing nuclear pyknosis and degeneration in observed neurons of fascia dentate 
& hilus of hippocamxpus (D): AD+MSCs (G4) (H&Ex40) showing relative nuclear pyknosis 
and degeneration in some neurons of fascia dentate & hilus of hippocampus.(E): 
AD+MSCs+NaHS (G5) (H&Ex40) showing nuclear pyknosis and degeneration in few neurons 
of fascia dentate & hilus of hippocampus.(F): AD+Kefir and GB (G6) (H&Ex40) showing 
nuclear pyknosis and degeneration in neurons of fascia dentate & hilus of hippocampus.(G): 
AD+MSCs+Kefir and GB (G7) (H&Ex40) showing mild nuclear nuclear pyknosis and 
degeneration in hippocampus regions.(H): AD+NaHS+Kefir and GB (G8) (H&Ex40) showing 
relative nuclear nuclear pyknosis and degeneration was observed in fascia dentate & hilus 
of hippocampus.(I): AD+MSCs+NaHS+Kefir and GB (G9) (H&Ex40)  showing relatively normal 
histological structures in neurons of fascia dentate and hilus of hippocampus. 
 
Mai M.Anwar et al., IJOAR, 2019 2:38 
IJOAR: https://escipub.com/international-journal-of-aging-research/                       13
3.3. Alzheimer’s disease induction by LPS 
resulted in marked increase in amyloid-β 
brain tissue disposition accompanied with a 
marked increase in oxidative stress 
Lipopolysaccharides (IP) injection resulted in a 
well-marked high Aβ level and MDA brain tissue 
level with a relevant decrease in GSH brain level 
accompanied with a significant increase in 
caspase-3 serum activity level with respect to 
the negative control group (G1). Regarding the 
administration of the combination therapy 
composed of NaHS as H2S exogenous donor 
whether administrated alone and /or MSCs and 
/or combination therapy of kefir and GB 
significantly resulted in attenuating the dramatic 
increase in Aβ brain tissue precipitated level with 
a significant decrease in oxidative stress MDA 
brain level and caspase-3 serum activity level 
accompanied with a relevant increase in 
antioxidant GSH brain level in different 
variations where the best results were observed 
in G9 as shown in figure 4(A, B,C&D).  
3.4. Histopathological examination of brain 
tissue 
Regarding brain tissue histopathological 
findings, normal neurons histological structure of 
hippocampal fascia dentate and hilus was 
detected in rat’s brain tissue (G1) as shown in 
figure 5(A). In LPS induced rat’s brain tissue 
(G2), neurons of the fascia dentate and hilus of 
the hippocampal circuit contained nuclear 
pyknosis and major degenerative regions 5(B). 
Regarding other groups of rats subjected to the 
suggested treatment protocol revealed an 
improvement in the major histological brain 
tissue examination following the induction of AD 
by LPS but within different variations reflected by 
the degree of decrease in brain tissue damage 
and regions of nuclear pyknosis  as shown in 
figure 5(C,D,E,F,G,H). While the most 
pronounced improvement was observed in 
group of rats treated with 
(MSCs+NaHS+Kefir+GB) (G9) as shown in 
figure 5 (I). 
4. Discussion 
Alzheimer’s disease (AD) in addition of being a 
main devastating form of dementia 
characterized by senile plagues, tangles (NFTs), 
and remarkable neuron loss [36], it can be 
ideally described as progressive two ways 
reversible – irreversible of neuro-immune 
interactions reflexing local and systemic 
inflammatory disorders [37-39].The main 
initiatory progression cascade of AD can be 
regarded to two main precipitating factors: 
genetic and inflammatory origin type. Regarding 
the inflammatory pathway, it can be initiated 
from LPS/TLR4 and ends with M1 microglia 
brain type macrophage stimulation with  
oxidative stress exaggerating factors release 
resulting in AD hallmarks brain disposition [40-
45]. 
  Accumulation of several extracellular amyloid-
beta (Aβ) and tau protein accompanied with 
marked elevated MAPK expression in brain 
tissue were all observed in the present work after 
the systematic administration of LPS. These 
results were associated with a clearly impaired 
cognitive and memory functions as evidenced by 
MWM test indicating their contribution in AD 
progression in the subjected examined rats. The 
observed findings are in accordance with those 
reported by [46-48], where an imbalanced 
aggregated accumulation of Aβ42 level in AD 
brain tissue was observed leading to 
vasoconstriction and dysregulation of vascular 
tone resulting in neurotoxicity, impaired blood 
flow within the cerebral structure, accelerated 
neuronal dysfunction and ended with total 
impaired memory function [49,50]. 
  In the present study, the obtained increase in 
caspase-3 serum activity level of LPS induced 
rats clearly clarify the potential role of the pro-
inflammatory cytokines and apoptosis in the 
induction of AD, activating oxidative stress and 
disposition of AD hallmarks in brain tissue 
leading to memory impairment [51,52]. Oxidative 
stress is one of the main triggering factors 
involved in AD pathology and aetiology including 
Aβ linked oligomers accumulation, tau 
phosphorylation, lipid dysregulation and over all 
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systemic inflammatory condition. Recently 
oxidative stress has been recognized as an 
important biomarker in identifying AD 
pathogenesis. Exaggerated oxidative stress 
suggested to be a result of excessive reactive 
oxygen species (ROS) and elevated lipid 
peroxidation (LPO) leading to unmaintained 
balance in the concentration of ions with 
elevated MDA brain level and well-marked 
decrease in the antioxidant brain GSH level [53-
55]. 
It was observed that the expression of 
cystathionine beta synthase (CBS) was down-
regulated in the brain tissue of LPS injected rats 
(G2). In accordance with our result, [59-58] 
reported a massive decrease in CBS relative 
expression in response to inflammatory 
cytokines resulted from AD induction by LPS 
with elevated MAPK expression indicating the 
role of CBS enzyme in down-regulating the 
predisposition and progression of AD in LPS 
induced rats. It has been also reported that S-
adenosyl-L-methionine (SAM) which is a CBS 
activator was observed to be reduced in AD 
brain resulting in accumulation of homocysteine 
in the serum of AD patients suggesting that CBS 
activity is reduced in AD brains [59]. Our results 
also revealed, that LPS challenged rats elicited 
a high expression level of ACAT in brain tissue. 
These findings are in a good agreement with that 
obtained by [60], where it reflects the implication 
of cholesterol and cholesteryl esters in the 
induction and perciptation of AD. Cholesterol 
content in cells can affect the production of Aβ, 
by the ability of modulating cholesterol enzymes 
activities including secretases [60-62]. Acyl-
coenzyme A: cholesterol acyl transferase 
(ACAT) is an endoplasmic reticulum (ER)-
resident enzyme responsible for the conversion 
of excess free cholesterol to cholesteryl esters 
playing an important role in cellular cholesterol 
homeostasis [61,62].  Importantly, it was 
reported that cholesteryl ester content is 
significantly elevated in various brain vulnerable 
regions affected by AD induction whether in 
human or even rats leading to an increase in 
membrane cholesterol level promoting the 
activity of amyliodgenic β-secretase and γ-
secretase enzymes [60]. 
It has been found that H2S level modulation in 
the brain has been associated with AD 
pathogenesis characterized by complete 
dysfunction and severe suppression of CBS 
enzyme playing a crucial role in the precipitation 
of AD [63-65].  Therefore the present study is 
undertaken to assert the crucial beneficial 
effects of sodium hydrogen sulphide (NaHS) as 
an exogenous H2S donor on the underlying 
neural cell damage and over all cerebral 
dysfunction as a result of AD neurotoxicity 
through its strategic declared neuromodulatory, 
anti-inflammatory, anti-apoptotic, cerebral 
vasodilation and neuroprotective effects [63-65]. 
In the current study, it was also found that intra-
peritoneal (IP) administration of NaHS to LPS 
injected rats improved the cognitive abilities of 
the examined rats through improving spatial 
memory acquisition and latency time MWM.  In 
accordance with our obtained findings, [66,67] 
reported that H2S plays an important crucial 
modulatory role in learning and memory 
functions by attenuating hippocampal damage 
and cognitive impairment in addition to 
protecting neurons against oxidative stress 
damage, neurotoxicity, and agitating apoptotic 
factors. It was also recorded that hydrogen 
sulphide down-regulates MAPK and tau protein 
expression in brain tissue of LPS induced rats by 
inhibiting Aβ production within neuron cells as a 
result of suppression of γ -secretase activity 
leading to a diminished of Aβ deposition and 
tangles formation with attenuating activated 
microglia and modulating marked anti-
inflammatory activity induced in the brain [68-
70].   
  Also data of the present study clearly proved 
the beneficial role of NaHS as exogenous H2S 
donor in suppressing the increasing level of 
caspase-3 activity accompanied with decrease 
in MDA levels and simultaneous elevation in 
GSH in accordance with the findings of [71] who 
reported that H2S exerts its neuro regenerating 
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effects by directly inhibiting free radicals and 
oxidative stress. H2S can prevent cytokines and 
oxidant-induced oxidative brain tissue damage 
by inhibiting the expression of pro-inflammatory 
factors through the down- regulation of NF-κB 
activation. Regarding the elevated ACAT brain 
tissue level in AD brain tissue, a significant 
decrease was observed. In Accordance with our 
results, [72] reported a decrease in ACAT 
expression and brain tissue cholesterol level as 
a result of CBS/H2S overexpression enhancing 
the degradation and engulfing of oligomeric 
Aβ1–42 by stimulating M1-M2 haemostasis [72-
74]. 
Our previous study demonstrated that 
intravenous delivery administration of MSCs 
improved the neurological functions of LPS- 
induced rats. The goal of the current study was 
to evaluate whether local intracerebral 
transplantation of MSCs could efficiently evoke 
the therapeutic effect of MSCs in AD induced 
rats. Regarding our previous study [12], the 
efficacy of intravenous administration of MSCs 
in relieving the neurotoxicity and 
neuropathlogical disorders was demonstrated in 
a significant decrease in the secretion of pro-
inflammatory cytokine TNF-α with up-regulation 
of anti-inflammatory factor IL-10. A stimulation in 
microglia brain type macrophage polarization 
towards M2 phenotype pathway which was 
suggested to be related to brain type 
neurotrophic factors secretions aiding in the 
survival of neural cells with a simultaneous 
marked decrease in bax relative expression [12]. 
Intracerebral injection of MSCs to LPS induced 
rats improved the impaired memory abilities 
reflecting the ability of MSCs to develop different 
types of neural cells to compensate damaged 
neural cells which was reflected on rat’s 
performance in MWM [75]. In the present study, 
intracerebral transplantation of MSCs to LPS 
challenged rats significantly resolved amyloid 
beta (Aβ) aggregates associated with down-
regulation of tau protein and MAPK brain tissue 
expression reflecting the ability of MSCs to 
decrease AD hallmarks disposition in brain 
tissues which can be related to the immune-
modulatory effect of MSCs. A decrease in serum 
Caspase-3 activity level was also observed as a 
result of suggested a acquired immune 
modulatory properties which polarize 
macrophages to engulf aggregated amyloid-β 
plaques [12,76-81]. 
  A relevant increase in brain tissue CBS relative 
expression was obtained in accordance with 
[74,82-83] Where MSCs are vital progenitor cells 
owing the capability to differentiate into vital cells 
with maintaining tissue homeostasis and 
proliferation of neural stem cells. While a 
suppression in oxidative stress brain tissue level 
(MDA) with a simultaneous increase in (GSH) 
was observed following intracerebral MSCs 
transplantation.These obtained results are in 
accordance with [12], where oxidative stress 
markers in brain tissue were suggested to be 
suppressed by intracerebral transplantation of 
MSCs as a result of expressing anti-
inflammatory cytokines involved in brain tissue 
repair introduced by MSCs via Bcl2 activation 
with attenuating Bax expression preventing 
brain damage [12,84].An additional beneficial 
action of transplanting MSCs intracerebrally 
within LPS induced AD in rats was their ability to 
suppress ACAT brain tissue relative expression 
level, which can not only be related to the lipid 
engulfing macrophage polarization effect but 
also to its ability to suppress inflammatory 
cascades such as TNF-α expression and 
caspase-3 where they play a vital role in up 
regulating the brain cholesterol ACAT level 
[12,85-86]. 
To demonstrate whether single administration of 
MSCs intracerebrally or NaHS as exogenous 
H2S sulphide donor gives a better effect on 
relieving AD precipitating factors to LPS induced 
rats or when both are given together, (G5) group 
was constructed. In our present study, it was 
found that a better results were observed in 
group of rats received both MSCs and NaHS. A 
better decrease in capase-3 serum activity level 
was observed in group of rats (G5) received both 
together as a result of the synergistic anti-
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apoptotic effects of both in addition to a relevant 
decrease in MDA brain tissue level with a 
marked increase in GSH tissue accompanied 
with a relevant increase as well in CBS tissue 
expression which can also be related to the 
synergistic antioxidant effect of both as well. The 
synergistic anti-inflammatory, anti-apoptotic, 
immune modulatory and macrophage lipid 
engulfing effects of MSCs received 
intracerebrally and NaHS administrated IP 
resulted in a marked suppression in MAPK, tau 
and ACAT protein brain tissue expression 
leading to a marked suppression in amyloid beta 
level in brain tissue level. 
In the present study the combined administration 
of kefir and GB significantly resolved the 
aggregation of Aβ that evidenced by the 
obtained decrease in Aβ level in brain tissue. 
This decrement in Aβ level found to be 
associated with significant decrease in the 
expression levels of tau protein and MAPK. The 
combined administration also significantly 
decreased Caspase-3 serum activity level. 
These findings clearly demonstrate the role of 
kefir and GB combination in combating the 
generation of AD plaques through the 
attenuation of amyloidogenic precipitation 
process. These findings are in accordance with 
those obtained by [87-90], who reported that GB 
inhibit β- secretase enzyme through direct anti-
inflammatory and immune modulatory actions 
[87-90]. 
 In our previous work we proved the ability of 
kefir to attenuate amyloid-β level in brain tissue 
through up regulating Il-10 and Bcl2 expression 
with inhibiting the release of pro-inflammatory 
cytokines TNF-α in brain tissue [12]. This 
powerful ability of kefir was also clearly proved 
in the current study through the attenuation of 
caspase-3 serum activity level with suppressing 
MAPK pathway accompanied with a relevant 
decrease in tau protein formation in the brain 
where these findings are in accordance with that 
obtained by [90], who proved the role of kefir in 
attenuating AD progression.  
   In our present study, the effect of 
administrating a combination medical therapy 
composed of kefir together with GB (G6), a 
decrease in brain tissue CBS relative expression 
was obtained where GB act as antioxidant, anti-
apoptotic and anti-amyloidogenic compound by 
scavenging free radicals with inhibiting the 
activation of TLR4/NF-κB induced by LPS 
through its antioxidant scavenging effect in 
addition to its ability to suppress BACE1 
expression and TNF-α level thereby blocking the 
formation of the apoptosomes and apoptotic 
cascades leading to a progressed improvement 
in cognitive impairment and neuronal damage 
against Aβ toxicity [88]. While kefir seemed to 
exert its effect in increasing CBS level through 
increasing useful anti-inflammatory cytokines 
such as IL-10 , suppression of TNF-alpha in 
addition to its antioxidant effect helping in 
regulating Aβ aggressive accumulation [12]. 
Mechanism underlying the suppression and 
elevation of MDA and GSH brain tissue level 
following the administration of kefir and GB in 
combination to LPS induced AD can be related 
to their antioxidant properties. [87], reported that 
GB plays an important role in combating the 
oxidative stress by inhibiting mitochondrial 
dysfunction preventing H2O2-inducing cell 
apoptosis which in turn inhibits mitochondria-
mediated caspases-3 activation with 
simultaneous increase in the activity of PI3K/Akt 
pathway suppressing the release of pro 
inflammatory cytokines such as TNF-α and bax 
expression accompanied with an increase in IL-
10 and bcl2 expression [87]. While the immune 
stimulant, anti-inflammatory and anti-oxidant 
activity of kefir in protecting neural tissues from 
oxidative stress suggested to be via decreasing 
the MDA brain tissue level where the bioactive 
peptides released during fermentation of kefir by 
the mean of proteolytic lactic acid bacteria which 
can scavenge ROS and inhibit MDA 
accompanied with an increase in GSH brain 
level [12,55]. 
  Concerning the effect of administrating the 
combination therapy of kefir with GB on ACAT 
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brain tissue expression, a down regulation in the 
expression of ACAT was observed [89], reported 
the ability of GB to inhibit the production of Aβ 
plaques by lowering the levels of circulating free 
cholesterol and intracellular cholesterol levels 
leading to miss folding in APP processing and 
amyloidogenesis by its antioxidant, anti-
inflammatory, immune modulatory and 
antiplatelet aggregation effects as well as the 
ability to polarize microglia to engulf excessive 
cholesterol due its immune modulatory effect 
[90].In our previous study, we observed the 
ability of kefir to decrease cholesterol and lipid 
level by increasing the discharge of bile acids 
[12]. Regarding the present study, we believe 
that kefir has the ability to suppress ACAT which 
in turn decrease cholesterol ester level and 
intracellular cholesterol due to its oxidative 
scavenging, anti-inflammatory and anti-oxidant 
effects leading to rapid down regulation of APP 
neurons protein content with reducing Aβ 
production in vivo and in vitro [85-90]. 
Administrating the combination therapy of kefir 
and GB together with MSCs (G7) or exogenous 
hydrogen sulphide donor NaHS (G8) resulted in 
a better progression in most subjected 
parameters than when receiving only Kefir and 
GB together as demonstrated in (G6) but with 
variable ratio which can be related to the dual 
modifying effect of the double given therapy. 
While it was also observed that group of rats 
(G9) received the suggested medical therapy 
composed of exogenous hydrogen sulphide 
donor (NAHS) with MSCs intracerebrally 
accompanied with kefir and GB, demonstrated 
the best results obtained among all other 
subjected groups in the present study protocol 
which can be related to  the exaggerated 
synergistic anti-inflammatory, anti-apoptotic 
immune-modulatory and antioxidant effect which 
was also observed through the shortest time 
spent by LPS induced rats (G9) in MWM 
indicating the relevant progression in the 
previously induced memory impairment. 
Concerning the histological examination of the 
current study, it had showed improvement in 
plaques formation with severe attenuation in 
pyknosis, congestion and oedema within 
numerous brain sections including hippocampus 
(subiculum, fascia dentate & hilus), striatum and 
cerebellum following administration of 
suggested medical protocol to LPS induced rats 
in different variations and patterns revealing the 
efficacy of the examined materials as suggested 
novel therapy for AD in our study protocol. 
5. Conclusion 
   The observed results can suggest that AD 
pathology seems to be an outcome of activated 
initiative - adaptive immune defence cascade in 
brain. Such initiatory inflammatory responses 
contribute not only to a local range of traumatic 
brain degenerative processes but also to an 
overall systemic inflammatory disorders that 
required to be revealed.The combination of the 
suggested medical strategy featuring NaHS, 
kefir and GB with MSCs can function as a potent 
neuroregenerative -modulator preventing the 
underlying pathological progressive hallmark 
brain damage cascade by protecting rats against 
LPS induced AD toxic aggregation with restoring 
brain deformities and behaviour abnormalities 
via attenuating and suppressing all excitatory 
inflammatory triggering factors. In addition to 
decreasing microglia M1 brain type polarization 
associated with exaggerated release of neuro-
regenerative and BDN factors, therefore our 
proposed therapeutic strategy can be clinically 
used. Meanwhile it is recommended in order to 
achieve the maximum safe effect of the 
suggested medical protocol to be received in a 
quaternary manner for a longer period of time to 
maintain irreversible maintained memory 
function with complete neurons restoration and 
regeneration. 
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